Northern Trust’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.8M | Sell |
921,271
-106,212
| -10% | -$900K | ﹤0.01% | 2208 |
|
|
2025
Q1 | $8.26M | Sell |
1,027,483
-26,882
| -3% | -$216K | ﹤0.01% | 2153 |
|
|
2024
Q4 | $9.47M | Buy |
1,054,365
+58,676
| +6% | +$527K | ﹤0.01% | 2158 |
|
|
2024
Q3 | $7.3M | Buy |
995,689
+15,705
| +2% | +$115K | ﹤0.01% | 2251 |
|
|
2024
Q2 | $5.6M | Sell |
979,984
-42,808
| -4% | -$244K | ﹤0.01% | 2333 |
|
|
2024
Q1 | $5.12M | Sell |
1,022,792
-44,383
| -4% | -$222K | ﹤0.01% | 2437 |
|
|
2023
Q4 | $9.59M | Buy |
1,067,175
+21,794
| +2% | +$196K | ﹤0.01% | 2106 |
|
|
2023
Q3 | $8.12M | Buy |
1,045,381
+35,392
| +4% | +$275K | ﹤0.01% | 2141 |
|
|
2023
Q2 | $9.78M | Buy |
1,009,989
+24,269
| +2% | +$235K | ﹤0.01% | 2079 |
|
|
2023
Q1 | $10.8M | Sell |
985,720
-41,397
| -4% | -$454K | ﹤0.01% | 1956 |
|
|
2022
Q4 | $4.44M | Buy |
1,027,117
+22,249
| +2% | +$96.1K | ﹤0.01% | 2554 |
|
|
2022
Q3 | $7.56M | Sell |
1,004,868
-14,449
| -1% | -$109K | ﹤0.01% | 2185 |
|
|
2022
Q2 | $10.2M | Buy |
1,019,317
+917,113
| +897% | +$9.22M | ﹤0.01% | 2014 |
|
|
2022
Q1 | $1.27M | Buy |
102,204
+728
| +0.7% | +$9.01K | ﹤0.01% | 3316 |
|
|
2021
Q4 | $2.32M | Buy |
101,476
+4,609
| +5% | +$105K | ﹤0.01% | 3149 |
|
|
2021
Q3 | $2.14M | Buy |
+96,867
| New | +$2.14M | ﹤0.01% | 3252 |
|